# A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

> **NCT00482261** · PHASE2 · COMPLETED · sponsor: **Peter MacCallum Cancer Centre, Australia** · enrollment: 150 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Lenalidomide
- **DRUG:** dexamethasone
- **DRUG:** aspirin

## Key facts

- **NCT ID:** NCT00482261
- **Lead sponsor:** Peter MacCallum Cancer Centre, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-08
- **Final completion:** 2014-02
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00482261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00482261, "A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00482261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*